Physician profile
Seth Jason Kanowitz
NPI 1649375759
$3,669.89
in general payments reported to CMS, 2019-2025
23 companies · $558 in 2025
The $558 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $912 · 2020: $827 · 2021: $78.76 · 2022: $367 · 2023: $577 · 2024: $350 · 2025: $558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,433 · Education: $51.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,433.14 |
| Education | $51.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $964.59 | 2019-2025 | |
| Intersect Ent, INC. | $814.56 | 2019-2022 | |
| Genzyme Corporation | $495.59 | 2019-2025 | |
| Glaxosmithkline, LLC. | $359.73 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $216.02 | 2019-2025 | Dupixent |
| Aerin Medical INC. | $205.35 | 2019-2025 | |
| Stryker Corporation | $125.79 | 2019-2025 | Xpress Loprofile |
| Medtronic, INC. | $87.46 | 2024-2025 | Stealthstation S8 Platform, Propel |
| Ambu INC. | $67.27 | 2022 | |
| Amgen INC. | $52.08 | 2025 | |
| Alk-Abello, INC | $47.42 | 2019-2022 | |
| Acera Surgical, INC. | $30.53 | 2024 | Restrata Wound Matrix |
| Kaleo, INC. | $25.61 | 2019-2020 | |
| Inspire Medical Systems, INC. | $24.36 | 2023 | Inspire |
| Medtronic USA, INC. | $21.70 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $20.20 | 2025 | Tula |
| Olympus America INC. | $19.88 | 2022 | |
| Cook Medical LLC | $19.06 | 2019 | |
| Merck Sharp & Dohme LLC | $16.59 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.18 | 2024 | Elaprase |
| Astrazeneca Pharmaceuticals LP | $16.14 | 2025 | Tezspire |
| Eisai INC. | $12.78 | 2019 | |
| Glenmark Therapeutics INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Kanowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.